SCM
CLYM

Sterling Capital Management’s Climb Bio CLYM Stock Holding History

Sterling Capital Management’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.89K Buy
+452
New +$4.67K ﹤0.01% 2523
2025
Q2 		– Sell
-479
Closed -$584 – 3430
2025
Q1 		$584 Sell
479
-462
-49% -$749 ﹤0.01% 2939
2024
Q4 		$1.69K Buy
941
+829
+740% +$3K ﹤0.01% 2823
2024
Q3 		$570 Buy
+112
New +$792 ﹤0.01% 2804

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sterling Capital Management's CLYM Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Climb Bio (CLYM) in Q2 2026: 452 shares worth $5.89K. The stake represents ﹤0.01% of the portfolio and ranks #2523 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in CLYM as recently as Q1 2025.

Sterling Capital Management first reported a position in CLYM in Q3 2024 and has held it in 4 quarters since. 109 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Sterling Capital Management held 452 shares of Climb Bio worth $5.89K as of Q2 2026.
  • Climb Bio was a new Sterling Capital Management position in Q2 2026.
  • Climb Bio made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2523 holding.
  • Sterling Capital Management first reported a position in Climb Bio in Q3 2024 and has held it in 4 quarters since.
  • 109 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.